LuciBriga 180mg
Original price was: $600.00.$494.93Current price is: $494.93.
LuciBriga is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
In Stock
Description
COMPOSITION:
Each film-coated tablet contains Brigatinib……………………………. 180 mg
INDICATION:
LuciBriga is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test.
DOSAGE AND USE:
90 mg orally once daily for the first 7 days; then increase to 180 mg orally once daily.
May be taken with or without food.
STORAGE:
in a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY:
LUCIUS PHARMACEUTICALS(LAO) CO., LTD
No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING:
Keep medicine out of reach of Children. Do not administer LuciBriga during Pregnancy and Lactation\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Reviews
There are no reviews yet.